The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Exploring the ocean for new drug developments: Marine pharmacology
Open accessAbstract
Disease ailments are changing the patterns, and the new diseases are emerging due to changing environments. The enormous growth of world population has overburdened the existing resources for the drugs. And hence, the drug manufacturers are always on the lookout for new resources to develop effective and safe drugs for the increasing demands of the world population. Seventy-five percentage of earth's surface is covered by water but research into the pharmacology of marine organisms is limited, and most of it still remains unexplored. Marine environment represents countless and diverse resource for new drugs to combat major diseases such as cancer or malaria. It also offers an ecological resource comprising a variety of aquatic plants and animals. These aquatic organisms are screened for antibacterial, immunomodulator, anti-fungal, anti-inflammatory, anticancer, antimicrobial, neuroprotective, analgesic, and antimalarial properties. They are used for new drug developments extensively across the world. Marine pharmacology offers the scope for research on these drugs of marine origin. Few institutes in India offer such opportunities which can help us in the quest for new drugs. This is an extensive review of the drugs developed and the potential new drug candidates from marine origin along with the opportunities for research on marine derived products. It also gives the information about the institutes in India which offer marine pharmacology related courses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Drug development from marine natural products
Molinski, T. F., Dalisay, D. S., Lievens, S. L., & Saludes, J. P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2487 · Cited by 1,186
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 666
Gerwick, W. H., & Moore, B. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.014 · Cited by 601
Martins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 572
Mayer, A., Rodríguez, A., Taglialatela-Scafati, O., & Fusetani, N. (2013) · Marine Drugs · doi:10.3390/md11072510 · Cited by 436
Marine natural products and their potential applications as anti-infective agents
Donia, M., & Hamann, M. T. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00655-8 · Cited by 425
Keyhole limpet hemocyanin (KLH): a biomedical review
Harris, J. R., & Markl∗, J. (1999) · Micron · doi:10.1016/s0968-4328(99)00036-0 · Cited by 373
Bio-mining the microbial treasures of the ocean: New natural products
Imhoff, J. F., Labes, A., & Wiese, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.001 · Cited by 346
Desbois, A. P., Mearns-Spragg, A., & Smith, V. J. (2009) · Marine Biotechnology · doi:10.1007/s10126-008-9118-5 · Cited by 296
Drugs and Cosmetics from the Sea
Kijjoa, A., & Sawangwong, P. (2004) · Marine Drugs · doi:10.3390/md202073 · Cited by 267
Newman, D., & Cragg, G. (2014) · Marine Drugs · doi:10.3390/md12010255 · Cited by 250 · cited 1×
“[31] Bryostatin 1 It has in vivo biological active molecule bryostatin 3 (one of the 20 known varieties) isolated from the bryozoan B. neritina.”
On the origins and biosynthesis of tetrodotoxin
Chau, R., Kalaitzis, J. A., & Neilan, B. A. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.04.001 · Cited by 209
Anand, T. P., Bhat, A. W., Shouche, Y. S., Roy, U., Siddharth, J., & Sarma, S. P. (2006) · Microbiological Research · doi:10.1016/j.micres.2005.09.002 · Cited by 193
Marine Antitumor Drugs: Status, Shortfalls and Strategies
Bhatnagar, I., & Kim, S. (2010) · Marine Drugs · doi:10.3390/md8102702 · Cited by 164
Radjasa, O. K., Vaske, Y. S. M., Navarro, G., Vervoort, H. C., Tenney, K., Linington, R. G., & Crews, P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.017 · Cited by 147
Drug Discovery from Marine Microbes
Gerwick, W. H., & Fenner, A. M. (2012) · Microbial Ecology · doi:10.1007/s00248-012-0169-9 · Cited by 135
The molecular mystique of tetrodotoxin
Moczydlowski, E. G. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.11.026 · Cited by 122
Miyaoka, H., Shimomura, M., Kimura, H., Yamada, Y., Kim, H., & Yusuke, W. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00818-7 · Cited by 106
Sawadogo, W. R., Schumacher, M. M., Teiten, M.-H., Cerella, C., Dicato, M. A., & Diederich, M. F. (2013) · Molecules · doi:10.3390/molecules18043641 · Cited by 97
Suganthy, N., Pandian, S. K., & Devi, K. P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.001 · Cited by 86
Antibody drug conjugates — Trojan horses in the war on cancer
Iyer, U. G., & Kadambi, V. J. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.07.005 · Cited by 80
Large-Scale Biotechnological Production of the Antileukemic Marine Natural Product Sorbicillactone A
Bringmann, G., Gulder, T. A. M., Lang, G., Schmitt, S., Stöhr, R., Wiese, J., Nagel, K., & Imhoff, J. F. (2007) · Marine Drugs · doi:10.3390/md502023 · Cited by 73
Marine Drugs: Implication and Future Studies
Vignesh, S., Raja, A., & Jam, R. A. (2010) · International Journal of Pharmacology · doi:10.3923/ijp.2011.22.30 · Cited by 71
Bergmann, W., & Stempien, M. F. (1957) · The Journal of Organic Chemistry · doi:10.1021/jo01363a009 · Cited by 53
Spinal actions of ω‐conotoxins, CVID , MVIIA and related peptides in a rat neuropathic pain model
Jayamanne, A., Jeong, H. J., Schroeder, C. I., Lewis, R. J., Christie, M. J., & Vaughan, C. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12251 · Cited by 33
Rashid, Z. M., Lahaye, É., Defer, D., Douzenel, P., Perrin, B., Bourgougnon, N., & Sire, O. (2009) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2009.01.002 · Cited by 28
Conopeptides as novel options for pain management
Daly, N. L., & Craik, D. J. (2011) · Drugs of the Future · doi:10.1358/dof.2011.36.1.1561066 · Cited by 18
Astellas' Drug Discovery Strategy: Focus on Oncology
Yanagita, Y., & Takenaka, T. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys014 · Cited by 4
Cited by
Karthikeyan, A., Joseph, A., & Nair, B. G. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00290-4 · Cited by 336
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
Van Weelden, G., Bobiński, M., Okła, K., Van Weelden, W. J., Romano, A., & Pijnenborg, J. M. A. (2019) · Marine Drugs · doi:10.3390/md17010032 · Cited by 330
Marine Collagen as A Promising Biomaterial for Biomedical Applications
Lim, Y.-S., Ok, Y.-J., Hwang, S.-Y., Kwak, J.-Y., & Yoon, S. (2019) · Marine Drugs · doi:10.3390/md17080467 · Cited by 328
Marine Fish Proteins and Peptides for Cosmeceuticals: A Review
Venkatesan, J., Anil, S., Kim, S.-K., & Shim, M. (2017) · Marine Drugs · doi:10.3390/md15050143 · Cited by 259
Marine Bioactive Peptides: Anti-Photoaging Mechanisms and Potential Skin Protective Effects
Zhang, X., Zhuang, H., Wu, S., Mao, C., Dai, Y., & Yan, H. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020063 · Cited by 45
Metadata
- Authors
- Malve, H.
- Venue
- Journal of Pharmacy And Bioallied Sciences
- Publisher
- Medknow
- Published
- 2016
- Volume
- 8
- Issue
- 2
- Pages
- 83
- ISSN
- 0975-7406 (ISSN-L)
- OpenAlex
- W2306077232
- Cited by
- 420
- References
- 29
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.